MAPT and Alzheimer disease: Studies have shown that LFUS treatment alone can reduce Aβ and tau lesions in AD animal models, and promote hippocampal neurogenesis, increase nerve growth factor content, activation of TRKA-related survival signaling pathways, and improvement of cognitive function (13, 14).